Author Archives for Adeline Chauvigné

What’s up France Biotech

After Paris, Lille and Marseille, France Biotech stopped over in Nantes to present an overview of the Life Science industry... View Article

Rédigé par Adeline Chauvigné, le 2017-06-13

What’s up France Biotech

After Paris, Lille and Marseille, France Biotech stopped over in Nantes to present an overview of the Life Science industry... View Article

IHU-CESTI : Epigenetics expert Jérémie Poschmann chooses Nantes

Attracting highly-talented researchers is certainly one of the great strengths of the Nantes IHU CESTI, in particular through the « Attractiveness »... View Article

Rédigé par Adeline Chauvigné, le 2017-06-13

IHU-CESTI : Epigenetics expert Jérémie Poschmann chooses Nantes

Attracting highly-talented researchers is certainly one of the great strengths of the Nantes IHU CESTI, in particular through the « Attractiveness »... View Article

Valneva to Present at Jefferies 2017 Global Healthcare Conference in New York

Valneva, a fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines, today announced that Thomas Lingelbach, President... View Article

Rédigé par Adeline Chauvigné, le 2017-06-07

Valneva to Present at Jefferies 2017 Global Healthcare Conference in New York

Valneva, a fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines, today announced that Thomas Lingelbach, President... View Article

In Cell Art ’s co-founder invited to present at the SF Nano Summer School

In Cell Art, a biotechnology company specializing in nanocarrier technologies named Nanotaxi® for unlocking the promise of nucleic acids to... View Article

Rédigé par Adeline Chauvigné, le 2017-06-07

In Cell Art ’s co-founder invited to present at the SF Nano Summer School

In Cell Art, a biotechnology company specializing in nanocarrier technologies named Nanotaxi® for unlocking the promise of nucleic acids to... View Article

Lemer Pax: Posijet®, the history of an exemplary partnership

The latest version of Posijet®, a mobile unit for the preparation and injection of high-energy radiopharmaceuticals, has become the compact... View Article

Rédigé par Adeline Chauvigné, le 2017-06-07

Lemer Pax: Posijet®, the history of an exemplary partnership

The latest version of Posijet®, a mobile unit for the preparation and injection of high-energy radiopharmaceuticals, has become the compact... View Article

OSE Immunotherapeutics: last news

OSE Immunotherapeutics present significant data on Selective Anti-SIRPa OSE-172 (Effi-DEM) OSE Immunotherapeutics announced that the Company presented in oral session significant data on... View Article

Portrait Olivier KITTEN, Affilogic

  Olivier KITTEN, Founder & CEO Affilogic   Atlanpole: What is the pitch of your business? Olivier Kitten: Affilogic is a... View Article

Rédigé par Adeline Chauvigné, le 2017-05-17

Portrait Olivier KITTEN, Affilogic

  Olivier KITTEN, Founder & CEO Affilogic   Atlanpole: What is the pitch of your business? Olivier Kitten: Affilogic is a... View Article

2017 BIO International Convention in San Diego

The 2017 Bio US will be held from June 19 to 22 in San Diego (USA). Atlanpole Biotherapies is preparing... View Article

Rédigé par Adeline Chauvigné, le 2017-05-17

2017 BIO International Convention in San Diego

The 2017 Bio US will be held from June 19 to 22 in San Diego (USA). Atlanpole Biotherapies is preparing... View Article

Valneva Reports Best Financial Results in the Company’s History

Valneva Reports Best Financial Results in the Company’s History with its First Year of Positive EBITDA in 2016 The Company... View Article

Rédigé par Adeline Chauvigné, le 2017-05-10

Valneva Reports Best Financial Results in the Company’s History

Valneva Reports Best Financial Results in the Company’s History with its First Year of Positive EBITDA in 2016 The Company... View Article

Ose Immunotherapeutics presented New Data at American Association for Cancer Reasearch annual meeting

OSE Immunotherapeutics Presented New Data at AACR* Annual Meeting 2017 on OSE-172 (Effi-DEM), Company’s Checkpoint Inhibitor Blocking Suppressive Myeloid Cells... View Article